Columbus Regional Research Institute ( Site 0047) — Columbus, Georgia

Public research footprint of Columbus Regional Research Institute ( Site 0047), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus, Type 2 · Crohn's Disease · Myelofibrosis (MF) · Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED)…

Recently updated registry entries

NCT04210115 — Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma… (Completed)
NCT06424288 — A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… (Recruiting)
NCT05757869 — A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Columbus Regional Research Institute ( Site 0047)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.